ArticleClinical, cosmetic and investigational dermatology2023

Adalimumab for Sintilimab-Induced Toxic Epidermal Necrolysis in a Patient with Metastatic Gastric Malignancy: A Case Report and Literature Review.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.